Literature DB >> 26631746

Peptidic degron in EID1 is recognized by an SCF E3 ligase complex containing the orphan F-box protein FBXO21.

Cuiyan Zhang1, Xiaotong Li2, Guillaume Adelmant3, Jessica Dobbins4, Christoph Geisen5, Matthew G Oser1, Kai W Wucherpfenning4, Jarrod A Marto3, William G Kaelin6.   

Abstract

EP300-interacting inhibitor of differentiation 1 (EID1) belongs to a protein family implicated in the control of transcription, differentiation, DNA repair, and chromosomal maintenance. EID1 has a very short half-life, especially in G0 cells. We discovered that EID1 contains a peptidic, modular degron that is necessary and sufficient for its polyubiquitylation and proteasomal degradation. We found that this degron is recognized by an Skp1, Cullin, and F-box (SCF)-containing ubiquitin ligase complex that uses the F-box Only Protein 21 (FBXO21) as its substrate recognition subunit. SCF(FBXO21) polyubiquitylates EID1 both in vitro and in vivo and is required for the efficient degradation of EID1 in both cycling and quiescent cells. The EID1 degron partially overlaps with its retinoblastoma tumor suppressor protein-binding domain and is congruent with a previously defined melanoma-associated antigen-binding motif shared by EID family members, suggesting that binding to retinoblastoma tumor suppressor and melanoma-associated antigen family proteins could affect the polyubiquitylation and turnover of EID family members in cells.

Entities:  

Keywords:  G0; cell cycle; degradation; pRB; ubiquitylation

Mesh:

Substances:

Year:  2015        PMID: 26631746      PMCID: PMC4687553          DOI: 10.1073/pnas.1522006112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  SCF and Cullin/Ring H2-based ubiquitin ligases.

Authors:  R J Deshaies
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

2.  Identification and characterization of a novel human cDNA encoding a 21 kDa pRb-associated protein.

Authors:  H Wen; S Ao
Journal:  Gene       Date:  2001-01-24       Impact factor: 3.688

3.  EID-2, a novel member of the EID family of p300-binding proteins inhibits transactivation by MyoD.

Authors:  Aimin Ji; Diem Dao; Jiexiao Chen; W Robb MacLellan
Journal:  Gene       Date:  2003-10-30       Impact factor: 3.688

4.  A novel EID-1 family member, EID-2, associates with histone deacetylases and inhibits muscle differentiation.

Authors:  Satoshi Miyake; Yuka Yanagisawa; Yasuhito Yuasa
Journal:  J Biol Chem       Date:  2003-02-13       Impact factor: 5.157

5.  A novel Rb- and p300-binding protein inhibits transactivation by MyoD.

Authors:  W R MacLellan; G Xiao; M Abdellatif; M D Schneider
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

6.  A transcriptional inhibitor targeted by the atypical orphan nuclear receptor SHP.

Authors:  Ann Båvner; Lotta Johansson; Gudrun Toresson; Jan-Ake Gustafsson; Eckardt Treuter
Journal:  EMBO Rep       Date:  2002-04-18       Impact factor: 8.807

7.  The oncogenic activity of cyclin E is not confined to Cdk2 activation alone but relies on several other, distinct functions of the protein.

Authors:  Christoph Geisen; Tarik Moroy
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

8.  A novel E1A-like inhibitor of differentiation (EID) family member, EID-2, suppresses transforming growth factor (TGF)-beta signaling by blocking TGF-beta-induced formation of Smad3-Smad4 complexes.

Authors:  Ho-Jae Lee; Jin Kyung Lee; Satoshi Miyake; Seong-Jin Kim
Journal:  J Biol Chem       Date:  2003-11-11       Impact factor: 5.157

9.  Acetylation regulates the differentiation-specific functions of the retinoblastoma protein.

Authors:  Don X Nguyen; Laurel A Baglia; Shih-Min Huang; Christina M Baker; Dennis J McCance
Journal:  EMBO J       Date:  2004-03-25       Impact factor: 11.598

10.  Interactions between the Nse3 and Nse4 components of the SMC5-6 complex identify evolutionarily conserved interactions between MAGE and EID Families.

Authors:  Jessica J R Hudson; Katerina Bednarova; Lucie Kozakova; Chunyan Liao; Marc Guerineau; Rita Colnaghi; Susanne Vidot; Jaromir Marek; Sreenivas R Bathula; Alan R Lehmann; Jan Palecek
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

View more
  5 in total

Review 1.  Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteins.

Authors:  Nana Zheng; Zhiwei Wang; Wenyi Wei
Journal:  Int J Biochem Cell Biol       Date:  2016-02-06       Impact factor: 5.085

2.  Tandem Affinity Purification and Mass Spectrometry (TAP-MS) for the Analysis of Protein Complexes.

Authors:  Guillaume Adelmant; Brijesh K Garg; Maria Tavares; Joseph D Card; Jarrod A Marto
Journal:  Curr Protoc Protein Sci       Date:  2019-02-01

3.  Prediction of tumor location in prostate cancer tissue using a machine learning system on gene expression data.

Authors:  Osama Hamzeh; Abedalrhman Alkhateeb; Julia Zheng; Srinath Kandalam; Luis Rueda
Journal:  BMC Bioinformatics       Date:  2020-03-11       Impact factor: 3.169

4.  Structural dynamics shape the fitness window of alanine:glyoxylate aminotransferase.

Authors:  Mirco Dindo; Stefano Pascarelli; Davide Chiasserini; Silvia Grottelli; Claudio Costantini; Gen-Ichiro Uechi; Giorgio Giardina; Paola Laurino; Barbara Cellini
Journal:  Protein Sci       Date:  2022-05       Impact factor: 6.725

5.  Circulating miR-17 as a promising diagnostic biomarker for lung adenocarcinoma: evidence from the Gene Expression Omnibus.

Authors:  Erna Jia; Na Ren; Rongkui Zhang; Changyu Zhou; Jinru Xue
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.